Gaia AG trials digital health app Liebria for primary hypertension
A clinical trial is underway to evaluate the effectiveness of the Liebria digital health application in managing primary hypertension.
Asset / Drug
Drug and asset intelligence for Liebria with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.